コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 mmary gland development as a new category of peroxisomal disorders.
2 the pathogenesis of the two major classes of peroxisomal disorders.
3 prove to be useful in the diagnosis of some peroxisomal disorders.
4 for the study of pathogenetic mechanisms in peroxisomal disorders.
5 d shed light on retinopathy in patients with peroxisomal disorders.
6 for monitoring aberrant lipid metabolism in peroxisomal disorders.
7 inked adrenoleukodystrophy (X-ALD) and other peroxisomal disorders.
8 e that mice with a PEX2 gene deletion have a peroxisomal disorder and provide an important model to s
9 s fatty acid accumulates in people with some peroxisomal disorders and is traditionally related to ne
10 impact of ether glycerophospholipids (GP) in peroxisomal disorders and other diseases makes them sign
16 d adrenoleukodystrophy (X-ALD), an inherited peroxisomal disorder, is caused by mutations in the ABCD
17 kodystrophy, representing the other group of peroxisomal disorders, is caused by the lack of the adre
18 >C18:0) contribute to their toxic levels in peroxisomal disorders of fatty acid metabolism, such as
20 cts from children diagnosed with generalized peroxisomal disorders were screened by continuous flow-n
21 X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder with impaired beta-oxidation of ver
22 X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder with impaired very-long-chain fatty
23 ctive in certain patients suffering from the peroxisomal disorder Zellweger syndrome, and with car1,